# Formoterol in Diabetes

> **NCT07022418** · PHASE2 · RECRUITING · sponsor: **Medical University of South Carolina** · enrollment: 120 (estimated)

## Conditions studied

- Diabetic Nephropathies
- Diabetic Kidney Disease

## Interventions

- **DRUG:** Formoterol furmarate (20 μg)

## Key facts

- **NCT ID:** NCT07022418
- **Lead sponsor:** Medical University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-01
- **Primary completion:** 2026-12
- **Final completion:** 2027-11
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-02-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07022418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07022418, "Formoterol in Diabetes". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT07022418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*